Preliminary observation of 99mtc-thymine imaging in breast neoplasms

Nuclear Medicine Communications

Volumn 22, Issue 10, 2001, Pages 1133-1137

  Gutfilen, B ^a   Rodrigues, E ^a   Soraggi, R ^a   Barbosa Da Fonseca, L H ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

99mTc Thymine; Breast cancer; Cancer diagnosis; Early detection

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M THYMINE; TECHNETIUM TC 99M-THYMINE; THYMINE; NUCLEOTIDE; TECHNETIUM 99M; THYMINE TC 99M; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOPSY; BREAST TUMOR; FEMALE; HUMAN; MAMMOGRAPHY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; ADOLESCENT; AGED; BREAST CALCIFICATION; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; DRUG UPTAKE; EARLY DIAGNOSIS; ISOTOPE LABELING; PALPATION; PRECURSOR;

ADULT; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; THYMINE;

EID: 0034739977     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200110000-00013     Document Type: Review

References (19)

1. Kesley JL, Gammon MD. The epidemiology of breast cancer. Cancer 1991; 41: 146-165.
2. Broeders MJ, Verbeck AL. Breast cancer epidemiology and risk factors. Q J Nucl Med 1997; 41: 179-188.
3. Buscombe JR, Khalkhali I. Scintimammography with single-photon tracers. In: Khalkhali I, Maublant JC, Goldsmith S, eds. Nuclear oncology — diagnosis and therapy. Philadelphia: Lippincott Williams & Wilkins, 2001: 273-387.
4. Fenlon HM, Phelan NC, O’Sullivan P, Tierney S, Gorey T, Ennis JT. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology 1997; 205: 214-220.
5. Greestein OS, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologicpathologic correlation. Radiology 1994; 190: 485-493.
6. Turkat TJ, Klein BD, Polan RL, Richman RH. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 1994; 4: 563-568.
7. Palmedo H, Schumburg A, Grunwald F, Mallmann P, Krebs D, Biersack HJ. Technetium-99m-MIBI scintimammography for suspicious breast lesions. Nucl Med 1996; 37: 626-626.
8. Piccolo S, Lastoria S, Mainolfi C, Muto P, Bazzicalupo L, Salvatore M. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995; 36: 718-724.
9. Bombardieri E, Crippa F, Maffioli L, Draisma A, Chiti A, Agresti R, Greco M. Nuclear medicine approaches for detection of axillary lymph node metastases. Q J Nucl Med 1998; 42: 54-65.
10. Tanigawa N, Morimoto H, Dohmae N, Shimomatsuya T, Takahashi D, Muraoka R. in vitro growth ability and chemosensitivity of gastric and colorectal cancer cells assessed with the human tumor clonogenic assay and thymidine incorporation assay. Eur J Cancer 1992; 28: 31-34.
11. León E, Rey A, Savio E, López J, Kremer E, León A. 99mTc-ADP: agente potential para la deteccion in vivo de tumores. Rev Esp Med Nuclear 1993; XII: 266.
12. Gutfilen B, Ribeiro BA, Bernardo-Filho M. Thymine labeled with technetium-99m: radiochemical control. In: Allen J, Voges R, eds. Synthesis and applications of isotopically labelled compounds. John Wiley and Sons Ltd., 1995: 395-398.
13. Gutfilen B, Ribeiro BLA, Mattos MF, Silva CR, Bernardo-Filho M. Labeling of thymine with 99m-technetium: a suggestion of a chemical model. Arq Biol Tecnol 1996; 39: 69-74.
14. Gutfilen B, Ribeiro BLCA, Fonseca LMB, Bernardo-Filho M. Use of 99mTc-thymine as a radiopharmaceutical: preliminary studies. Eur J Nucl Med 1994; 21: 127.
15. Léon AS, Rey AM, Leon ET et al. Labelling control and radiopharmacological evaluation of 99mTc-adenosine 5′diphosphate (99mTc-ADP) as tumour seeking agent. Q J Nucl Med 1996; 40: 170-175.
16. Elmaleh DR, Zamecnik PC, Castranovo FP, Strauss HW, Rapaport E. 99mTc-labeled nucleotides as tumor-seeking radiodiagnostic agents. Proc Natl Acad Sci USA 1984; 81: 918-921.
17. Tanigawa N, Masuda Y, Shimomatsuya T, Fuji IH, Muraoka R, Tanaka T. Thymidine uptake in vitro as a prognostic indicator for primary gastric cancer. Cancer 1993; 72: 2883-2888.
18. Tsujitani S, Konishi I, Suzuki K et al. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients. J Exp Clin Cancer Res 2000; 19(2): 189-195.
19. Huynh PT, Jarolimek AM, Daye S. The false-negative mammogram. Radiographics 1998; 18: 1137-1154.